R&D/Clinical Trials

Latest News

Daiichi Sankyo, AstraZeneca Launch Phase III Trials of Datopotamab Deruxtecan in Advanced Nonsquamous Non-Small Cell Lung Cancer
Daiichi Sankyo, AstraZeneca Launch Phase III Trials of Datopotamab Deruxtecan in Advanced Nonsquamous Non-Small Cell Lung Cancer

October 30th 2024

The trials will investigate datopotamab deruxtecan in combination with treatments including rilvegostomig, osimertinib, and chemotherapy in patients with nonsquamous non-small cell lung cancer.

Merck, Moderna Launch Phase III Trial of V940 in Combination with Keytruda for Resectable Non-Small Cell Lung Cancer
Merck, Moderna Launch Phase III Trial of V940 in Combination with Keytruda for Resectable Non-Small Cell Lung Cancer

October 28th 2024

How to Enhance DEI in Clinical Trials
How to Enhance DEI in Clinical Trials

October 24th 2024

Nipocalimab Demonstrates Sustained Disease Control in Adolescents with Generalized Myasthenia Gravis
Nipocalimab Demonstrates Sustained Disease Control in Adolescents with Generalized Myasthenia Gravis

October 16th 2024

Mirikizumab Demonstrates Superiority to Ustekinumab in Treating Crohn Disease
Mirikizumab Demonstrates Superiority to Ustekinumab in Treating Crohn Disease

October 16th 2024

Video Interviews
Podcasts

More News